New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ALKS;LTM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
10:19 EDTLTMHigh option volume stocks
Subscribe for More Information
08:06 EDTLTMLife Time Fitness reports Q4 adjusted EPS 71c, consensus 69c
Subscribe for More Information
08:04 EDTLTMLife Time Fitness sees FY15 EPS $3.15-$3.35, consensus $3.33
Sees FY15 revenue $1.39B-$1.42B, consensus $1.4B.
08:03 EDTLTMLife Time Fitness says board continues to review strategic alternatives
As previously announced, the company’s board of directors continues to review strategic alternatives, including the exploration of a conversion of real estate assets into a REIT, which the Board believes could provide substantial benefits to the company and its shareholders. The company is unable to comment further at this time but expects to provide shareholders with additional information, as appropriate.
February 25, 2015
08:30 EDTALKSAlkermes price target raised to $79 from $75 at Leerink
Leerink raised its price target for Alkermes shares to $79 to reflect probability-of-success weighted ALKS 8700 in multiple sclerosis revenue. The firm views the company's Q4 results as strong, but notes its 2015 outlook missed consensus due to higher than expected operating expenses. Leerink says the 2015 guidance reflects Alkermes' maturing pipeline. It keeps an Outperform rating on the stock.
06:19 EDTALKSAlkermes pipeline eases loss of pain program, says Citigroup
Citigroup says Alkermes' pipeline programs and the continued growth of its base business help moderate the disappointment of the discontinuation of novel pain program ALKS-7106. Citi lowered its price target for Alkermes shares to $83 from $85 and keeps a Buy rating on the stock.
05:57 EDTALKSUBS says remain on sidelines with respect to Alkermes
Subscribe for More Information
February 24, 2015
10:06 EDTALKSHigh option volume stocks
High option volume stocks: CHGG LBTYK SMH RCAP NGLS OTEX TERP CNC ALKS AMT
08:56 EDTALKSOn The Fly: Pre-market Movers
Subscribe for More Information
08:54 EDTALKSAlkermes 7106 halt overshadows Q4 beat, says Credit Suisse
Subscribe for More Information
07:06 EDTALKSAlkermes sees FY15 adjusted EPS 27c-40c, consensus 20c
Subscribe for More Information
07:03 EDTALKSAlkermes reports Q4 EPS 11c, consensus 4c
Subscribe for More Information
07:01 EDTALKSAlkermes announces phase 1 results for ALKS 7106, will not proceed to phase 2
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use